Aimed Alliance Comments on Oregon’s PDAB Process
On February 25, 2024, Aimed Alliance sent a letter to the Oregon Prescription Drug Affordability Board regarding its current patient…
Browsing: Aimed Activity
Aimed Alliance Submits Letter of Support for Biomarker Legislation
Aimed Alliance recently submitted letters of support to the Washington and Iowa legislatures urging them to swiftly pass biomarker legislation…
UPCOMING WEBINAR: Prescription Drug Affordability Boards 101
Join Aimed Alliance for a FREE webinar on March 18, 2024 at 11AM ET – 12:00PM ET. Ensuring prescription drug affordability…
New Resources for Consumers & Employers: DC Decision Bans Copay Accumulators
On September 29, 2023, the United States District Court for the District of Columbia held that the 2021 NBPP, which…
NEW White Paper on Alternative Funding Programs
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
MDPC’s New Policy Paper on Parkinson’s Disease Care Access
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease: Improving Treatment While Working Toward…
Aimed Alliance Releases 2023 Annual Impact Report
In 2023, Aimed Alliance engaged in a wide variety of activities to protect and enhance the rights of health care…
Aimed Alliance Release New Resources on PDABs
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards (PDABs). These boards, established at…
FDA Authorizes Florida’s Drug Importation Program
On January 5, 2024, the U.S. Food and Drug Administration (FDA) approved Florida’s Agency for Health Care Administration drug importation…
Aimed Alliance Submits Comment on 2025 Medicare Part D Rule
On January 5, 2024, Aimed Alliance submitted a comment on the Medicare Program Contract Year 2025 proposal. The comment expressed…